PATHOGENETIC APPROACH IN TREATMENT OF DIABETIC AND VENOUS TROPHIC ULCERS USING PLASMATHERAPY AND LASER THERAPY
DOI:
https://doi.org/10.21272/eumj.2020;8(4):458-465Keywords:
trophic ulcers, diabetes mellitus, chronic venous insufficiency, photodynamic therapy, plasma therapyAbstract
Introduction. In Ukraine more than 13,000 lower limb amputations are performed per year, of which about 8,000 are due to vascular lesions, and more than 3,000 are associated with diabetes mellitus (DM).
Objective: to improve the effectiveness of treatment of patients with diabetic and venous trophic ulcers (TU) of the lower extremities by applying a pathogenetic approach using plasma therapy and laser therapy.
Materials and methods. The study involved 63 patients with TU, of which 32 were with chronic venous insufficiency (CVI) (group 1) and 31 patients with T2DM, moderate severity, compensation stage with diabetic foot syndrome II (group 2).
Results. The effectiveness of photodynamic therapy (PDT) in group 1 was assessed by the VCSS-1 and VCSS-2 scales. At baseline, the total score of clinical severity of CVI was 20.9 points, and two weeks later – 15.71 points, which shows an improvement by 24.83% (p≤0.05). The effectiveness of PDT in group 2 was assessed by the S(AD) SAD-1 scales at baseline and S(AD) SAD-2 at 2 weeks. The overall score on the scale S(AD) SAD-1 was 13.91 points, two weeks later it improved by 11.65% (12.29 points), which shows a much slower rate of normalization of the clinical picture in patients with diabetes compared with CVI.
The effectiveness of plasma therapy in group 1 was assessed by the VCSS-1 and VCSS-3 scales. The total score of clinical severity of CVI after 6 weeks of treatment was 9.72 points, indicating an improvement in clinical status by 53.49% from baseline (20.9 points) (p≤0.05). In group 2, the evaluation of the effectiveness of plasma therapy was based on a comparison of the scales S(AD) SAD-1 and S(AD) SAD-3. The overall score of clinical severity at 6 weeks was 6.39 points, indicating an improvement by 54.06% from baseline (13.91 points).
Analysis of the ulcer healing dynamics in group 1 revealed 0 points (no active ulcers) in 87.5% of patients (28 patients), while in the remaining 4 patients the size of active ulcers was 1 point. In group 2, the dynamics of the area reduction showed slower results: in 74.2% of patients the TU area was 2 points, 0 points were achieved in 12.9% patients, in the remaining patients (12.9%) – 4 points.
Conclusions. Due to using of combined scheme of basic therapy, supplemented with PDT at the initial stage and plasma therapy in the granulation phase, it was possible to improve the dynamics of the rate of healing of TU and reduce the duration of treatment.
Downloads
References
Chan M. Global report on diabetes: World Health Organization 2016. WHO Library Cataloguing-in-Publication Data, 2016, pp. 6-31.
Saeedi P, Petersohn I, Salpea P. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes research and clinical practice. 2019;157:107843:2-10. doi: 10.1016/j.diabres.2019.107843
Narres M, Kvitkina T, Claessen H, Droste S, Schuster B, Morbach S. Incidence of lower extremity amputations in the diabetic compared with the non-diabetic population: A systematic review. PLoS ONE. 2017;12(8):1-28. doi: 10.1371/journal.pone.0182081
Ligi D, Croce L, Mannello F. Molecular Sciences Chronic Venous Disorders: The Dangerous, the Good, and the Diverse. International Journal of Molecular Sciences. 2018;19(9):2-9. doi: 10.3390/ijms19092544
Wittens C, Davies A, Broholm R, Cavezzi A. Editor's Choice - Management of Chronic Venous Disease Clinical Practice Guidelines of the European Society for Vascular Surgery. European Journal of Vascular and Endovascular Surgery. 2015;49(6):678-737. doi: 10.1016/j.ejvs.2015.02.007
Stacey M. Chronic Venous Insufficiency and Leg Ulceration: Principles and Vascular Biology. Mechanism of vascular disease: a reference book for vascular specialist. Vol. 25. Australia: University of Adelaide Press, 2011, pp.459–474.
Gorobeyko MB. [Diabetic foot syndrome. A contrived or real threat]. Clinical Endocrinology and Endocrine Surgery. 2017;4(1):81-89.
Ivanova YuV, Pulyaeva IV, Cherkasheninov EG. [Complex treatment of trophic ulcers of venous etiology]. Harkivska hirurgichna shkola. 2020;5-6(92-93):127-130.
Sinha S, Sreedharan S. Management of venous leg ulcers in general practice - a practical guideline. Australian Family Physician. 2014;43(9):594-598.
Alavi A, Sibbald RG, Phillips TJ. What’s new: management of venous leg ulcers: approach to venous leg ulcers. Journal of the American Academy of Dermatology. 2016;74:627-640.
Riddle MC. Diabetes Advocacy: Standards of Medical Care in Diabetes. American Diabetes Association. Diabetes Care. 2019;42(1):182-183. doi:10.2337/dc19-S016.
Passman M, McLafferty R, Lentz M. Validation of Venous Clinical Severity Score (VCSS) with other venous severity assessment tools from the American Venous Forum, National Venous Screening Program. Journal of Vascular Surgery. 2011;54(6):2-9. doi:10.1016/j.jvs.2011.05.117
Duzhiy ID, Nikolaienko AS, Popadynets VP, Kravets OV, Hresko IY, Holubnichyi SO. Reparative processes features in trophic ulcers caused by diabetes mellitus with the use of platelet-rich plasma. Wiad Lek. 2020;73(10):2150-5.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 T. A. Kharchenko, A. S. Ivanova, O. K. Melekhovets, V. F. Orlovskyi, Iu. V. Melekhovets

This work is licensed under a Creative Commons Attribution 4.0 International License.

























